HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

bis(alpha- furancarboxylato)oxovanadium(IV)

structure in first source

Also Known As:

BFOV cpd

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Organometallic Compounds: 64
  - bis(alpha-furancarboxylato)oxovanadium(IV): 1

Experts

1.	Chen, Xi-Zhu: 1 article (10/2008)
2.	Li, Ling: 1 article (10/2008)
3.	Liu, Wei-Ping: 1 article (10/2008)
4.	Niu, Yan-Fen: 1 article (10/2008)
5.	Tian, Chang-Fu: 1 article (10/2008)
6.	Xie, Ming-Jin: 1 article (10/2008)
7.	Zuo, Yi-Qing: 1 article (10/2008)

Related Diseases

1.	Insulin Resistance 10/01/2008 - "Bis(alpha-furancarboxylato)oxovanadium(IV) prevents and improves dexamethasone-induced insulin resistance in 3T3-L1 adipocytes." 10/01/2008 - "Previous studies showed that bis(alpha-furancarboxylato)oxovanadium(IV) (BFOV), an orally active anti-diabetic organic vanadium complex, could improve insulin resistance in animals with type 2 diabetes. "
2.	Type 2 Diabetes Mellitus (MODY) 10/01/2008 - "Previous studies showed that bis(alpha-furancarboxylato)oxovanadium(IV) (BFOV), an orally active anti-diabetic organic vanadium complex, could improve insulin resistance in animals with type 2 diabetes. "

Related Drugs and Biologics

1.	Vanadium
2.	Dexamethasone (Maxidex)